This five-day course is open to clinicians offering STI services. The curriculum includes didactic presentations by experienced faculty; one day of experiential training in laboratory techniques; one clinical day with a preceptor; and, “hands-on” training in a directed sexual/reproductive health examination by genital teaching associates. Class size is limited to 8-10 participants. Continuing Education is provided. Schedule – class schedule set annually. The cost for this class is $250.00
CME activities with Joint Sponsors: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and STD/HIV Prevention Training Center at Johns Hopkins. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Centers for Disease Control and Prevention designates this live for a maximum of 32.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 3.3 CEU's for this program.
This activity has been designated as Knowledge-Based.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Paul Nyirjesy and he wishes to disclose he receives research grants and honorariums from Genesis Biotechnology Group, Medicis, Novadign and Hologics. Also Dr. Richard Sterling wishes to disclose he receives research grants and honorariums from Gilead, Abbott/Abbvie, Genentech, Merck, BMS, Vertex, Salix Boehringer Ingelheim and Bayer. Ms. Judy Wessell wishes to disclose she receives honorariums from ViiV, BMS, and Gilead.
Planning committee discussed conflict of interest with Dr. Paul Nyirjesy, Dr. Richard Sterling and Ms. Judy Wessell to ensure there is no bias.
Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Khalil Ghanem’s discussion on STIs especially Gonorrhea and Chlamydia. He will be discussing NAATS for extragenital testing currently recommended by CDC. Dr. Paul Nyirjesy’s lecture on Vaginitis/Cervicitis will be discussing treatments for complicated forms of vaginitis, for which there are no labeled products. None of these are products produced by the commercial interests labeled in table 3 on disclosure and recommendations are based on peer-reviewed guidelines such as the CDC STD Treatment Guidelines. Dr. Richard Sterling’s lecture on Hepatitis will be discussing use of DAA in treating HCV. Dr. Michael Rein’s lecture on Bacterial and Viral STI’s will discuss data supported newer approaches to treatment.
CDC does not accept commercial support.
Jeanne Hoover 410-396-0621 Jeanne.Hoover@baltimorecity.gov